Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dr Foster'S Essentials
WARNING LETTER
•Dr Foster'S Essentials

FDA WARNING_LETTER - Dr Foster'S Essentials

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA issued a Warning Letter to Ms. Cynthia Foster regarding products promoted on www.drfosteressentials.com. The FDA determined that products such as "Adrenal Support," "Blood Detox Formula," and "Candida-G" are promoted for conditions that classify them as drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)].

The website's "Search by Health Concern" feature, "List of Health Concerns" webpage, and "Ailment Reference Guide" link products to the cure, mitigation, treatment, or prevention of numerous diseases, including Attention Deficit, Crohn's, Cancer, Diabetes Type I, Hepatitis, Colon Cancer, and Epilepsy. Specific therapeutic claims and personal testimonials on the website further establish these products as drugs.

These products are considered "new drugs" under section 201(p) of the Act [21 U.S.C. § 321(p)] because they are not generally recognized as safe and effective for their promoted uses and lack prior FDA approval. Marketing them without approval violates section 505(a) of the Act [21 U.S.C. § 355(a)].

Furthermore, the products are misbranded under section 502(f)(1)

Company
Dr Foster'S Essentials
Office
Los Angeles District Office
Person
  • Alonza E. Cruse (Director)
Open in Dashboard

ID · 9fc9d442-6c56-4f10-af2f-30e8995ac095

Violation Codes9
21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 321(ff)(2)(A)(i)21 U.S.C. 33221 U.S.C. 33421 CFR 211

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.